Clinical pharmacokinetics of paclitaxel monotherapy: an updated literature review
TB Stage, TK Bergmann, DL Kroetz - Clinical pharmacokinetics, 2018 - Springer
Paclitaxel is an anticancer agent efficacious in the treatment of ovarian, breast, and lung
cancer. Due to a strong link between the pharmacokinetics and therapeutic efficacy of …
cancer. Due to a strong link between the pharmacokinetics and therapeutic efficacy of …
Chemical diversity of biologically active metabolites in the sclerotia of Inonotus obliquus and submerged culture strategies for up-regulating their production
W Zheng, K Miao, Y Liu, Y Zhao, M Zhang… - Applied microbiology …, 2010 - Springer
Abstract Inonotus obliquus (Fr.) Pilat is a white rot fungus belonging to the family
Hymenochaetaceae in the Basidiomycota. In nature, this fungus rarely forms a fruiting body …
Hymenochaetaceae in the Basidiomycota. In nature, this fungus rarely forms a fruiting body …
Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor …
W Eiermann, T Pienkowski, J Crown… - Journal of clinical …, 2011 - ascopubs.org
Purpose Anthracyclines, taxanes, and alkylating agents are among the most active agents in
treatment of adjuvant breast cancer (BC), but the optimal schedule for their administration is …
treatment of adjuvant breast cancer (BC), but the optimal schedule for their administration is …
Clinical relevance of hepatic and renal P‐gp/BCRP inhibition of drugs: An international transporter consortium perspective
The role of P‐glycoprotein (P‐gp) and breast cancer resistance protein (BCRP) in drug–drug
interactions (DDIs) and limiting drug absorption as well as restricting the brain penetration of …
interactions (DDIs) and limiting drug absorption as well as restricting the brain penetration of …
Baicalin suppresses lung carcinoma and lung metastasis by SOD mimic and HIF-1α inhibition
G Du, G Han, S Zhang, H Lin, X Wu, M Wang… - European journal of …, 2010 - Elsevier
The dose-related toxicity of anticancer drugs in chemotherapy of clinical carcinoma is the
major obstacle to prolonged survival, we want to investigate selective therapeutic efficacy of …
major obstacle to prolonged survival, we want to investigate selective therapeutic efficacy of …
Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration
SY Saad, TAO Najjar, M Alashari - Journal of biochemical and …, 2004 - Wiley Online Library
The higher incidence of cardiotoxicity of doxorubicin (DOX)/paclitaxel (PTX) combination
compared with DOX alone remains to be a major obstacle against effective …
compared with DOX alone remains to be a major obstacle against effective …
Validated HPLC‐UV Method for Simultaneous Estimation of Paclitaxel and Doxorubicin Employing Ion Pair Chromatography: Application in Formulation Development …
Though paclitaxel (PTX) and doxorubicin (DOX) are amongst the most widely used and
investigated drug pair for combination chemotherapy but surprisingly, not a single validated …
investigated drug pair for combination chemotherapy but surprisingly, not a single validated …
A systematic review on drug interactions in oncology
RP Riechelmann, ED Saad - Cancer investigation, 2006 - Taylor & Francis
Objectives: To systematically review drug interactions in oncology. Methods: We searched
PubMed for eligible articles and online databases abstracts of major oncology meetings …
PubMed for eligible articles and online databases abstracts of major oncology meetings …
Total flavonoids of Daphne genkwa root significantly inhibit the growth and metastasis of Lewis lung carcinoma in C57BL6 mice
W Zheng, X Gao, C Chen, R Tan - International immunopharmacology, 2007 - Elsevier
Daphne genkwa root has been traditionally used as an effective remedy to treat various
tumors. However, the active constituents for its antitumor potency have not been well …
tumors. However, the active constituents for its antitumor potency have not been well …
Индуцированная антрациклинами кардиотоксичность: механизмы развития и клинические проявления
МГ Матяш, ТЛ Кравчук, ВВ Высоцкая… - Сибирский …, 2008 - cyberleninka.ru
В обзоре представлены современные данные об антрациклиновой
кардиотоксичности, механизмах ее развития, предсказывающих факторах, факторах …
кардиотоксичности, механизмах ее развития, предсказывающих факторах, факторах …